Since 1996 WHN is the second oldest medical website on the net, second only to the American Medical Association, servicing over 35,000 physicians and scientists worldwide.
Non-Profit Trusted Source of Non-Commercial Health Information
By Bill Freeman Researchers have developed a so-called lab-on-a-chip (LOC) that is able to instantly detect cancer cells. Using the latest advances in nanotechnology, the device, which is smaller than a matchbox, works by exposing cells to a dye that adheres to cancer cells. The same technique is already in use in hospitals throughout the …
By Bill Freeman CardioPocket is a pocket-sized heart monitor that comes with a one-lead rhythm strip sewn inside a wallet. If a patient experiences chest pain all they have to do is place the strip on their chest and dial the number of the nearest monitoring center. The instant ECG is relayed to the monitoring …
By Bill Freeman UK researchers recently unveiled a new computer chip capable of analysing DNA samples within minutes. The credit card sized reusable chip analyses DNA in blood samples for a number of pathogens including the AIDS virus HIV as well as carrying out other diagnostic tests in just a few minutes. The chip will …
By Bill Freeman UK researchers are developing a hand-held heart monitor that will enable people to tell straight away if they have a problem that requires urgent medical attention. When the patient first gets the personal heart attack detector, they take an ECG by holding the device over their breastbone and placing electrodes on their …
By Bill Freeman Miniature chips that take snapshots of the activity of thousands of genes have enabled scientists to classify lung cancers at the genetic level as opposed to their appearance under the microscope. By determining the so-called genetic signature of tumors it will make it possible for doctors to determine between different types of …
By Bill Freeman In the not too distant future it may be possible to diagnose cancer by testing a single drop of a patient’s blood or urine, according to German company Epigenomics.Researchers at Epigenomics have developed a test that distinguishes normal DNA from that of cancerous cells by working out whether specific genes have been …